Skip to main content
Fig. 4 | EJNMMI Research

Fig. 4

From: Assessment of early metabolic progression in melanoma patients under immunotherapy: an 18F-FDG PET/CT study

Fig. 4

Plots of events of the studied patient cohort during the follow-up period after application of EORTC (n = 31 patients) (a) and PERCIMT (n = 29 patients) (b). The events depicted are: date of therapy commencement, date of uPMD, date of cPMD or remission of pseudoprogression, date of clinical progression, and date of death or last contact. For both sets of criteria, patients were dichotomized in those showing true progression/cPMD (upper part of the figures), and those showing pseudoprogression (lower part of the figures). *These patients did not show clinical disease progression according to the evaluation of the dermato-oncologists. In these cases, the red part of the lines of events corresponds to the time interval between remission of pseudoprogression in PET/CT and date of death or last contact

Back to article page